Call on Congress to Investigate Why Medicare Cannot Negotiate with Big Pharma


You pay twice as much for brand-name drugs in the United States as you would in Canada, Sweden, Japan or England.

Those countries — and many more — control drug prices by using their buying power to negotiate with Big Pharma.

But in the United States, Medicare is prohibited by law from negotiating.

The drug companies and their ARMY OF LOBBYISTS saw to that when Medicare Part D was created back in 2003.

Add Your Name to the Petition Calling on Congress to Investigate why Medicare Cannot Negotiate with Big Pharma